Gilbert R Kaufmann

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
    Gilbert R Kaufmann
    Division of Infectious Diseases and Hospital Epidemiology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    Clin Infect Dis 41:361-72. 2005
  2. doi CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
    Nina Khanna
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland
    Clin Infect Dis 47:1093-101. 2008
  3. ncbi Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
    Gilbert R Kaufmann
    Division of Infectious Diseases, University Hospital, Basel, Switzerland
    Antivir Ther 9:263-74. 2004
  4. ncbi CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
    Gilbert R Kaufmann
    Basel Center for HIV Research, Division of Infectious Diseases, University Hospital, Basel, Switzerland
    Arch Intern Med 163:2187-95. 2003
  5. doi Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
    Gilbert R Kaufmann
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland
    AIDS 25:441-51. 2011
  6. ncbi Immunological recovery and antiretroviral therapy in HIV-1 infection
    Manuel Battegay
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
    Lancet Infect Dis 6:280-7. 2006
  7. ncbi Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes
    Natasha Hansjee
    Institute for Medical Microbiology, University of Basel, Division of Infectious Diseases, Department of Internal Medicine, University Hospital Basel, Switzerland
    J Acquir Immune Defic Syndr 36:671-7. 2004
  8. ncbi Productivity costs and determinants of productivity in HIV-infected patients
    Pedram Sendi
    Division of Infectious Diseases, Basel University Hospital, Basel, Switzerland
    Clin Ther 26:791-800. 2004
  9. ncbi Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries
    Gilbert R Kaufmann
    Basel Center for HIV Research, Division of Infectious Diseases, University Hospital Basel, Switzerland
    Expert Opin Investig Drugs 11:1303-13. 2002
  10. ncbi Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion
    Don E Smith
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia
    AIDS Res Hum Retroviruses 19:189-99. 2003

Collaborators

Detail Information

Publications15

  1. ncbi Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
    Gilbert R Kaufmann
    Division of Infectious Diseases and Hospital Epidemiology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    Clin Infect Dis 41:361-72. 2005
    ..We studied the determinants and the clinical relevance of incomplete CD4 T cell restoration...
  2. doi CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
    Nina Khanna
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland
    Clin Infect Dis 47:1093-101. 2008
    ....
  3. ncbi Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
    Gilbert R Kaufmann
    Division of Infectious Diseases, University Hospital, Basel, Switzerland
    Antivir Ther 9:263-74. 2004
    ..Information about the virological response to sequential highly active antiretroviral therapy (HAART) for HIV infection is limited. The virological response to four consecutive therapies was evaluated in the Swiss HIV Cohort...
  4. ncbi CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
    Gilbert R Kaufmann
    Basel Center for HIV Research, Division of Infectious Diseases, University Hospital, Basel, Switzerland
    Arch Intern Med 163:2187-95. 2003
    ..Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)-1 infection allows recovery of CD4 T lymphocytes. Few studies have explored the long-term T-lymphocyte responses to HAART...
  5. doi Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
    Gilbert R Kaufmann
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland
    AIDS 25:441-51. 2011
    ..Interruptions of ART are still frequent. The long-term effect on CD4 T-cell recovery and clinical events remains unknown...
  6. ncbi Immunological recovery and antiretroviral therapy in HIV-1 infection
    Manuel Battegay
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
    Lancet Infect Dis 6:280-7. 2006
    ..In addition, immune reconstitution disease, an inflammatory syndrome associated with immunological recovery occurring days to weeks after the start of antiretroviral therapy, is briefly described...
  7. ncbi Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes
    Natasha Hansjee
    Institute for Medical Microbiology, University of Basel, Division of Infectious Diseases, Department of Internal Medicine, University Hospital Basel, Switzerland
    J Acquir Immune Defic Syndr 36:671-7. 2004
    ..The significant relationship between residual T-lymphocyte apoptosis and CD4 T-cell recovery suggests that persistent apoptosis may impede immune restoration...
  8. ncbi Productivity costs and determinants of productivity in HIV-infected patients
    Pedram Sendi
    Division of Infectious Diseases, Basel University Hospital, Basel, Switzerland
    Clin Ther 26:791-800. 2004
    ..In HIV-infected patients, reduced ability to work may be an important component of the societal costs of this disease. Few data about productivity costs in HIV-infected patients are available...
  9. ncbi Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries
    Gilbert R Kaufmann
    Basel Center for HIV Research, Division of Infectious Diseases, University Hospital Basel, Switzerland
    Expert Opin Investig Drugs 11:1303-13. 2002
    ....
  10. ncbi Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion
    Don E Smith
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia
    AIDS Res Hum Retroviruses 19:189-99. 2003
    ..Despite poorer prognostic markers at baseline ES subjects achieved responses similar to those of LS subjects after 1 year of treatment...
  11. ncbi Gynecomastia and potent antiretroviral therapy
    Christoph Strub
    AIDS 18:1347-9. 2004
  12. ncbi Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy
    Angela C Huttner
    University Hospital of Zurich, Zurich, Switzerland
    AIDS 21:939-46. 2007
    ..We examined the predictive factors for this phenomenon and assessed its impact on clinical progression during treatment in a large patient cohort...
  13. ncbi Impact of protease polymorphisms and viral fitness on human immunodeficiency virus (HIV) type 1 viremia in untreated HIV-1 infection
    Yvonne Märki
    J Infect Dis 185:1844-6. 2002
  14. ncbi The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy
    Gilbert R Kaufmann
    National Centre in HIV Epidemiology and Clinical Research, Sydney NSW, 2010, Australia
    AIDS 16:359-67. 2002
    ..To study the long-term immunological recovery in HIV-1-infected individuals receiving potent antiretroviral therapy (ART)...
  15. ncbi Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection
    Sharon R Lewin
    Department of Microbiology and Immunology, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria 3052, Australia
    J Immunol 169:4657-66. 2002
    ....